Upgrade to SI Premium - Free Trial

RxSight Inc. (RXST) PT Lowered to $7 at Stifel Amid U.S. Adoption Challenges

August 10, 2026 7:23 AM
Stifel analyst Tom Stephan lowered the price target on RxSight Inc. (NASDAQ: RXST) to $7.00 (from $8.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change